# Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C

> **NCT00638144** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 300 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00638144
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638144, "Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00638144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*